|
Volumn 12, Issue 12, 2000, Pages 1213-1218
|
Central administration of orexin A suppresses basal and domperidone stimulated plasma prolactin
|
Author keywords
Domperidone; Hypocretin; Intracerebroventricular; Orexin; Prolactin
|
Indexed keywords
CORTICOTROPIN RELEASING FACTOR;
DOMPERIDONE;
DOPAMINE;
DOPAMINE RECEPTOR BLOCKING AGENT;
GONADORELIN;
MELANIN CONCENTRATING HORMONE;
NEUROTENSIN;
OREXIN A;
PROLACTIN;
PROTIRELIN;
SOMATOSTATIN;
VASOACTIVE INTESTINAL POLYPEPTIDE;
VASOPRESSIN;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
CONTROLLED STUDY;
DOPAMINE RELEASE;
DOPAMINERGIC SYSTEM;
DOSE RESPONSE;
DRUG EFFECT;
EXPLANT;
HORMONE RELEASE;
HYPOPHYSIS CELL;
HYPOTHALAMUS;
IN VITRO STUDY;
MALE;
NONHUMAN;
PRIORITY JOURNAL;
PROLACTIN BLOOD LEVEL;
PROLACTIN RELEASE;
PROTEIN SECRETION;
RAT;
TUBEROHYPOPHYSEAL TRACT;
VASOPRESSIN RELEASE;
ANIMALS;
CARRIER PROTEINS;
CELLS, CULTURED;
CORTICOTROPIN-RELEASING HORMONE;
DOMPERIDONE;
DOPAMINE ANTAGONISTS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
HYPOTHALAMUS;
INJECTIONS, INTRAVENTRICULAR;
INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS;
LUTEINIZING HORMONE;
MALE;
NEUROPEPTIDES;
NEUROTENSIN;
PITUITARY GLAND, ANTERIOR;
PROLACTIN;
RATS;
RATS, WISTAR;
RECEPTORS, DOPAMINE D2;
RECEPTORS, G-PROTEIN-COUPLED;
RECEPTORS, NEUROPEPTIDE;
SOMATOSTATIN;
THYROTROPIN-RELEASING HORMONE;
VASOACTIVE INTESTINAL PEPTIDE;
|
EID: 0033708644
PISSN: 09538194
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-2826.2000.00582.x Document Type: Article |
Times cited : (76)
|
References (37)
|